{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:24:31Z","timestamp":1772033071181,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100016804","name":"Natural Science Foundation of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20220530151002004"],"award-info":[{"award-number":["JCYJ20220530151002004"]}],"id":[{"id":"10.13039\/100016804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jpet.2025.103684","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T02:18:12Z","timestamp":1756433892000},"page":"103684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Koningic acid reduces tumor activity in neuroendocrine prostate cancer by inhibiting glycolysis"],"prefix":"10.1016","volume":"392","author":[{"given":"Haixia","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meixiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpet.2025.103684_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.critrevonc.2014.05.008","article-title":"Neuroendocrine differentiation in prostate cancer: current and emerging therapy strategies","volume":"92","author":"Conteduca","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jpet.2025.103684_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108255","article-title":"Current and emerging therapies for neuroendocrine prostate cancer","volume":"238","author":"Alabi","year":"2022","journal-title":"Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.jpet.2025.103684_bib3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41585-021-00490-0","article-title":"Molecular events in neuroendocrine prostate cancer development","volume":"18","author":"Wang","year":"2021","journal-title":"Nat Rev Urol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103684_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s11658-024-00536-2","article-title":"New insights into the role of mitochondrial metabolic dysregulation and immune infiltration in septic cardiomyopathy by integrated bioinformatics analysis and experimental validation","volume":"29","author":"Li","year":"2024","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"10.1016\/j.jpet.2025.103684_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2024.2364433","article-title":"Neuroendocrine gene subsets are uniquely dysregulated in prostate adenocarcinoma","volume":"25","author":"Naranjo","year":"2024","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jpet.2025.103684_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejca.2019.08.011","article-title":"Clinical features of neuroendocrine prostate cancer","volume":"121","author":"Conteduca","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpet.2025.103684_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.778758","article-title":"Neuroendocrine carcinoma as an independent prognostic factor for patients with prostate cancer: a population-based study","volume":"12","author":"Yao","year":"2021","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.jpet.2025.103684_bib8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.cmet.2017.08.017","article-title":"A predictive model for selective targeting of the Warburg effect through GAPDH inhibition with a natural product","volume":"26","author":"Liberti","year":"2017","journal-title":"Cell Metab"},{"issue":"8","key":"10.1016\/j.jpet.2025.103684_bib9","first-page":"787","article-title":"Heptelidic acid, a sesquiterpene lactone, inhibits etoposide-induced apoptosis in human leukemia U937 cells","volume":"19","author":"Kim","year":"2009","journal-title":"J Microbiol Biotechnol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103684_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12020-021-02822-x","article-title":"Antitumor activity of koningic acid in thyroid cancer by inhibiting cellular glycolysis","volume":"75","author":"Jing","year":"2022","journal-title":"Endocrine"},{"issue":"15","key":"10.1016\/j.jpet.2025.103684_bib11","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/pros.21383","article-title":"PC3 is a cell line characteristic of prostatic small cell carcinoma","volume":"71","author":"Tai","year":"2011","journal-title":"Prostate"},{"issue":"6","key":"10.1016\/j.jpet.2025.103684_bib12","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3390\/cancers13061483","article-title":"Cross-resistance to abiraterone and enzalutamide in castration resistance prostate cancer cellular models is mediated by AR transcriptional reactivation","volume":"13","author":"Simon","year":"2021","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.jpet.2025.103684_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112812","article-title":"Elevated FBXW10 drives hepatocellular carcinoma tumorigenesis via AR-VRK2 phosphorylation-dependent GAPDH ubiquitination in male transgenic mice","volume":"42","author":"Lin","year":"2023","journal-title":"Cell Rep"},{"issue":"14","key":"10.1016\/j.jpet.2025.103684_bib14","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1038\/sj.onc.1210027","article-title":"p85 regulatory subunit of PI3K mediates cAMP\u2013PKA and estrogens biological effects on growth and survival","volume":"26","author":"Cosentino","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.jpet.2025.103684_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/srep35660","article-title":"AKT\/GSK3\u03b2 signaling pathway is critically involved in human pluripotent stem cell survival","volume":"6","author":"Romorini","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jpet.2025.103684_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13045-019-0840-4","article-title":"Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K\/AKT\/GSK3\u03b2 signalling pathway in renal cell carcinoma","volume":"13","author":"Zhu","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jpet.2025.103684_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fnins.2015.00022","article-title":"Lactate is always the end product of glycolysis","volume":"9","author":"Rogatzki","year":"2015","journal-title":"Front Neurosci"},{"issue":"Pt 3","key":"10.1016\/j.jpet.2025.103684_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.semcancer.2022.05.007","article-title":"Molecular mechanisms underlying the development of neuroendocrine prostate cancer","volume":"86","author":"Liu","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jpet.2025.103684_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.580617","article-title":"Androgen receptor signaling and metabolic and cellular plasticity during progression to castration resistant prostate cancer","volume":"10","author":"Uo","year":"2020","journal-title":"Front Oncol"},{"issue":"13","key":"10.1016\/j.jpet.2025.103684_bib20","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1016\/j.bmc.2015.04.004","article-title":"Anticancer activity of koningic acid and semisynthetic derivatives","volume":"23","author":"Rahier","year":"2015","journal-title":"Bioorg Med Chem"},{"issue":"10","key":"10.1016\/j.jpet.2025.103684_bib21","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s12272-019-01185-2","article-title":"Warburg effect and its role in tumourigenesis","volume":"42","author":"Lebelo","year":"2019","journal-title":"Arch Pharm Res"},{"issue":"21","key":"10.1016\/j.jpet.2025.103684_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115787","article-title":"The Warburg effect explained: integration of enhanced glycolysis with heterogeneous mitochondria to promote cancer cell proliferation","volume":"24","author":"Alberghina","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"23","key":"10.1016\/j.jpet.2025.103684_bib23","doi-asserted-by":"crossref","first-page":"14276","DOI":"10.1021\/acs.jmedchem.0c01013","article-title":"Why all the fuss about oxidative phosphorylation (OXPHOS)?","volume":"63","author":"Xu","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpet.2025.103684_bib24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.brainresbull.2019.01.007","article-title":"RNAi-mediated knockdown of DJ-1 leads to mitochondrial dysfunction via Akt\/GSK-3\u00df and JNK signaling pathways in dopaminergic neuron-like cells","volume":"146","author":"Zhang","year":"2019","journal-title":"Brain Res Bull"},{"issue":"3","key":"10.1016\/j.jpet.2025.103684_bib25","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s11064-016-2044-4","article-title":"AKT\/GSK3\u03b2 signaling in glioblastoma","volume":"42","author":"Majewska","year":"2017","journal-title":"Neurochem Res"},{"issue":"6","key":"10.1016\/j.jpet.2025.103684_bib26","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41419-018-0641-7","article-title":"Hirsutine induces mPTP-dependent apoptosis through ROCK1\/PTEN\/PI3K\/GSK3\u03b2 pathway in human lung cancer cells","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis"},{"issue":"8","key":"10.1016\/j.jpet.2025.103684_bib27","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1248\/bpb.b19-00050","article-title":"Qiliqiangxin attenuates oxidative stress-induced mitochondrion-dependent apoptosis in cardiomyocytes via PI3K\/AKT\/GSK3\u03b2 signaling pathway","volume":"42","author":"Zhao","year":"2019","journal-title":"Biol Pharm Bull"},{"issue":"6","key":"10.1016\/j.jpet.2025.103684_bib28","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","article-title":"ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis","volume":"97","author":"Wang","year":"2023","journal-title":"Arch Toxicol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:32:46Z","timestamp":1762209166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525398976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0022356525398976"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103684","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Koningic acid reduces tumor activity in neuroendocrine prostate cancer by inhibiting glycolysis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103684"}}